Company news

Currenc Group Inc. news in 2020

Currenc Group Inc.'s news releases, calls and decks from 2020, newest first.

View company

CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17

December 13, 2020

Nicole Kidman Partners With Sera Labs A CURE Pharmaceutical Company As A Strategic Business Partner And Global Brand Ambassador

December 9, 2020

Nicole Kidman Partners With SeraLabs, a CURE Pharmaceutical Company, as a Strategic Business Partner and Global Brand Ambassador

December 7, 2020

CURE Pharmaceutical Issues Letter to Shareholders

November 17, 2020

CURE Pharmaceutical Closes $10 Million Financing

November 1, 2020

CURE Pharmaceutical’s® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology

October 28, 2020

CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company

September 23, 2020

CURE Pharmaceutical to Present at Two Virtual Events in September

September 1, 2020

Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, to be acquired by CURE Pharmaceutical in a $20 Million Transaction

July 29, 2020

CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction

July 27, 2020

CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel

July 14, 2020

CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements

July 7, 2020

CURE Pharmaceutical Appoints Chief Business Officer

June 15, 2020

CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition

June 8, 2020

CURE Pharmaceutical [OTCQB: CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary

June 2, 2020

CURE Pharmaceutical [OTCQB: CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

April 20, 2020

CURE Pharmaceutical [OTCQB: CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific

February 11, 2020

UPDATE – CURE Pharmaceutical [OTCQB: CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

February 4, 2020

CURE Pharmaceutical [OTCQB: CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

February 4, 2020